Cargando…

RNF6 promotes chronic myelogenous leukemia cell proliferation and migration by stabilizing vimentin via multiple atypical ubiquitinations

Detalles Bibliográficos
Autores principales:	Zhang, Hongxia, Zhong, Yueya, He, Yuanming, Xu, Yujia, Ren, Ying, Zhuang, Haixia, Sun, Tong, Zhu, Zhigang, Mao, Xinliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chongqing Medical University 2023
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425833/ https://www.ncbi.nlm.nih.gov/pubmed/37588191 http://dx.doi.org/10.1016/j.gendis.2023.04.004

Ejemplares similares

Induction of zinc finger protein RNF6 auto-ubiquitination for the treatment of myeloma and chronic myeloid leukemia
por: Zhuang, Haixia, et al.
Publicado: (2022)

Atypical Presentation of Chronic Myelogenous Leukemia
por: Updyke, Katelyn Mariko, et al.
Publicado: (2017)

Human Platelets Effectively Kill K‐562 Cells, a Chronic Myelogenic Leukemia Cell Line, in vitro
por: Sagawa, Terutaka, et al.
Publicado: (1990)

Secretion of Transforming Growth Factor‐ß by Human Myelogenous Leukemic Cells and Its Possible Role in Proliferation of the Leukemic Cells
por: Komatsu, Keiko, et al.
Publicado: (1989)

Atypical ubiquitin ligase RNF31: the nuclear factor modulator in breast cancer progression
por: Zhu, Jian, et al.
Publicado: (2016)

The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation
por: Zhu, J, et al.
Publicado: (2014)

RNF6 promotes the migration and invasion of breast cancer by promoting the ubiquitination and degradation of MST1
por: Huang, Yajuan, et al.
Publicado: (2022)

RNF6 promotes the migration and invasion of breast cancer by promoting the ubiquitination and degradation of MST1
por: Huang, Yajuan, et al.
Publicado: (2022)

Suppression of USP7 induces BCR-ABL degradation and chronic myelogenous leukemia cell apoptosis
por: Jiang, Shuoyi, et al.
Publicado: (2021)

Correction: The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation
por: Zhu, J., et al.
Publicado: (2018)

BECN1 promotes the migration of NSCLC cells through regulating the ubiquitination of Vimentin
por: Cheng, Zhujun, et al.
Publicado: (2019)

The Role of Tissue-Specific Ubiquitin Ligases, RNF183, RNF186, RNF182 and RNF152, in Disease and Biological Function
por: Okamoto, Takumi, et al.
Publicado: (2020)

UCHL3 promotes hepatocellular carcinoma cell migration by de-ubiquitinating and stabilizing Vimentin
por: Ma, Qiancheng, et al.
Publicado: (2023)

RNF11 at the Crossroads of Protein Ubiquitination
por: Mattioni, Anna, et al.
Publicado: (2020)

The ubiquitin ligase HERC4 suppresses MafA transcriptional activity triggered by GSK3β in myeloma by atypical K63-linked polyubiquitination
por: Zhang, Zubin, et al.
Publicado: (2023)

Chronic myelogenous leukemia in Libya
por: Mehdi, Itrat, et al.
Publicado: (2012)

Chronic myelogenous leukemia on target
por: Némethová, Veronika, et al.
Publicado: (2018)

RNF112-mediated FOXM1 ubiquitination suppresses the proliferation and invasion of gastric cancer
por: Zhang, Shengwei, et al.
Publicado: (2023)

Atypical Chronic Myelogenous Leukemia, BCR-ABL1 Negative: Diagnostic Criteria and Treatment Approaches
por: Diamantopoulos, Panagiotis T., et al.
Publicado: (2021)

RNF26 binds perinuclear vimentin filaments to integrate ER and endolysosomal responses to proteotoxic stress
por: Cremer, Tom, et al.
Publicado: (2023)

Expression and Activity of Fyn Mediate Proliferation and Blastic Features of Chronic Myelogenous Leukemia
por: Singh, Melissa M., et al.
Publicado: (2012)

Overexpression of the long non-coding RNA PVT1 is correlated with leukemic cell proliferation in acute promyelocytic leukemia
por: Zeng, Chengwu, et al.
Publicado: (2015)

RNF180 Inhibits Proliferation and Promotes Apoptosis of Colorectal Cancer Through Ubiquitination of WISP1
por: Wei, Feng, et al.
Publicado: (2021)

BCL10 regulates RNF8/RNF168-mediated ubiquitination in the DNA damage response
por: Zhao, Hongchang, et al.
Publicado: (2014)

Characterization of the Roles of Vimentin in Regulating the Proliferation and Migration of HSCs during Hepatic Fibrogenesis
por: Wang, Pei-Wen, et al.
Publicado: (2019)

Chronic myelogenous leukemia in ulcerative colitis
por: Katsanos, Konstantinos H., et al.
Publicado: (2011)

Chronic Myelogenous Leukemia (CML) in the elderly
por: Balducci, Lodovico, et al.
Publicado: (2014)

Bosutinib in the management of chronic myelogenous leukemia
por: Amsberg, Gunhild Keller-von, et al.
Publicado: (2013)

Acute Myelogenous Leukemia and Febrile Neutropenia
por: Herbers, Alexandra, et al.
Publicado: (2009)

Ubiquitin ligase RNF125 targets PD-L1 for ubiquitination and degradation
por: Wei, Meng, et al.
Publicado: (2022)

The ubiquitin ligase RNF5 determines acute myeloid leukemia growth and susceptibility to histone deacetylase inhibitors
por: Khateb, Ali, et al.
Publicado: (2021)

Circumvention of Atypical Multidrug Resistance with Tumor Necrosis Factor
por: Cimoli, Guido, et al.
Publicado: (1994)

Atypical Mitosis in Gastric Intestinal Metaplasia in Japanese Patients
por: Rubio, Carlos A., et al.
Publicado: (1993)

MiR-570 inhibits cell proliferation and glucose metabolism by targeting IRS1 and IRS2 in human chronic myelogenous leukemia
por: Zhao, Hong, et al.
Publicado: (2017)

Saponins From Paris forrestii (Takht.) H. Li Display Potent Activity Against Acute Myeloid Leukemia by Suppressing the RNF6/AKT/mTOR Signaling Pathway
por: Lu, Qin, et al.
Publicado: (2018)

Complexities of genetic diagnosis illustrated by an atypical case of congenital hypoplastic anemia
por: Claassen, David, et al.
Publicado: (2018)

RNF168 cooperates with RNF8 to mediate FOXM1 ubiquitination and degradation in breast cancer epirubicin treatment
por: Kongsema, M, et al.
Publicado: (2016)

Applications of Microarray Technology to Acute Myelogenous Leukemia
por: Goswami, Rashmi S., et al.
Publicado: (2008)

Biomarkers for determining the prognosis in chronic myelogenous leukemia
por: Sweet, Kendra, et al.
Publicado: (2013)

Supremacy of nanoparticles in the therapy of chronic myelogenous leukemia
por: Janani, Gopalarethinam, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qkpdqbl1qfkkh4gkn5ql46f5lq